Skip to main content
Clinical Trials/JPRN-UMIN000002562
JPRN-UMIN000002562Completed未知

Reviewing of the bowel preparation for Colon Capsule Endoscopy - Colon Capsule Preparation Study

ational Cancer Center Hospital0 sites60 target enrollmentStarted: October 13, 2009Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18years-old to 79years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1) Subjects who have a swallowing disorder 2) Subject who has 2 < bowel movements per week. 3) Subjects who take nonsteroidal anti-inflammatory drug for long period (more than 6 months) 4) Subjects who take anti-thrombotic medicine or anticoagulant 5) Subjects who take iron pills 6) Subjects who take morphine hydrochloride 7) Subjects who take tranquilizers 8) Subjects who have a history of allergic reaction to the following medicines (1 - 4) used in this study. These medicines are used normally in the clinical situations in Japan. 1. Magnesium citrate solution, Polyethylene glycol 2. Mosapride citrate 3. Dimethicone, Pronase, Sodium bicarbonate 4. Bisacodyl 5.Glycerin 6.sennoside 9) Subjects who are pregnant 10) Subjects who are scheduled to have MRI examination within the next 2 weeks 11) Subjects who have a cardiac pacemaker implanted or other medical electronic devices applied in the body 12) Subjects who have a history of digestive tract anastomosis 13) Subjects who have a history of abdominal operation 14) Subjects who have a suspected symptom or who have a history of intestinal obstruction or intestinal stenosis 15) Subjects who have a small intestine tumor or who have a suspected symptom of it 16) Subjects who have an advanced large intestine cancer or who have a suspected symptom of it 17) Subjects who have a diabetes 18) Subjects who have a diverticulum in digestive tract 19) Subjects who have a history of radiotherapy 20) Subjects who have an accompanying cancerous peritonitis 21) Subjects who have a renal dysfunction 22) Subjects who have a heart disease 23) Subjects who have a clone disease or ulcerative colitis 24) Subjects who have a familial adenomatous polyposis (FAP) or hereditary nonpolyposis colorectal cancer (HNPCC) 25) Subjects who had a incomplete total colonoscopy before 26) Other cases where doctor considers it inappropriate

Investigators

Similar Trials